Salix Coronary Plaque vs Viz RV/LV

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Artrya
VS
by Viz.ai

AI Verdict

Tool A is designed for the diagnosis of coronary artery disease by analyzing coronary artery plaque and stenosis from CCTA scans. In contrast, Tool B focuses on pulmonary embolism risk stratification by automating right and left ventricular diameter measurements from CTPA scans. While both are FDA-cleared AI tools for cardiac imaging analysis, they address distinct clinical questions and utilize different CT imaging protocols.

Choose Salix Coronary Plaque if…

Choose Salix Coronary Plaque if your primary need is a comprehensive, near real-time assessment of coronary artery plaque and stenosis from CCTA scans. This tool is ideal for cardiologists and radiologists requiring detailed quantification of plaque burden, identification of high-risk plaque features, and calcium scoring to aid in the rapid diagnosis and risk stratification of coronary artery disease patients.

View Salix Coronary Plaque →

Choose Viz RV/LV if…

Choose Viz RV/LV if your focus is on rapid, automated risk stratification for suspected pulmonary embolism using RV/LV ratio measurements from CTPA scans. This tool is best suited for emergency departments and care teams needing quick identification of right ventricular strain and seamless integration into a broader PE solution for enhanced care coordination and timely intervention.

View Viz RV/LV →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Salix Coronary Plaque Viz RV/LV
Pricing Subscription model Unknown
Deployment Cloud-based (Amazon Web Services), web-based software application Cloud-based
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz RV/LV

Viz RV/LV (Tool B) offers superior usability by integrating seamlessly into a broader care coordination platform with mobile access, AI-powered alerts, and a HIPAA-compliant communication platform, which significantly streamlines workflow and communication for care teams [JSON, cite: 4]. Salix Coronary Plaque (Tool A) focuses on efficient web-based analysis and automated report generation, which is valuable but less comprehensive in terms of overall care coordination and real-time communication across a team [JSON, cite: 6, 7].

Clinical Value

Salix Coronary Plaque

Both tools are FDA-cleared and provide critical diagnostic information for their respective conditions. However, Salix Coronary Plaque (Tool A) offers a more comprehensive and detailed analysis of coronary artery disease by detecting and quantifying various high-risk plaque features, stenosis, and calcifications, which can lead to more personalized treatment and preventative care [JSON, cite: 7]. Viz RV/LV (Tool B), while crucial for PE risk stratification, focuses on a single ratio measurement [JSON].

Pricing & Value

Salix Coronary Plaque

Salix Coronary Plaque (Tool A) explicitly states a per-scan assessment model with a clear US CPT reimbursement rate of US$950, providing transparent and tangible revenue generation potential for healthcare providers [JSON, cite: 6]. Viz RV/LV (Tool B)'s pricing is not publicly available, making its value proposition less transparent in terms of direct financial return [JSON].

Enterprise Readiness

Viz RV/LV

Viz RV/LV (Tool B) demonstrates superior enterprise readiness by explicitly stating HIPAA compliance and the presence of a Business Associate Agreement (BAA) [JSON]. Furthermore, Viz.ai provides extensive documentation of its security and compliance posture through a Trust Center, including SOC 2 Type II, ISO certifications, and GDPR compliance, which are crucial for large-scale healthcare deployments.

Innovation

Salix Coronary Plaque

Salix Coronary Plaque (Tool A) demonstrates higher innovation in its core AI capabilities by providing detailed, near real-time detection and quantification of complex coronary plaque features, including high-risk characteristics, from CCTA scans [JSON, cite: 6, 7]. While Viz RV/LV (Tool B)'s AI-powered alerts and care coordination are innovative for workflow, Tool A's advanced diagnostic depth in identifying subtle, critical plaque morphology represents a more significant leap in AI-driven image analysis for disease characterization.

Support & Docs

Viz RV/LV

Viz.ai (Tool B) offers a significantly more robust and transparent support and documentation ecosystem, including a comprehensive online knowledge base, dedicated customer resources, and 24/7 urgent support. Artrya (Tool A) mentions a user guide but does not detail the breadth of support services or documentation availability to the same extent.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Salix Coronary Plaque Viz RV/LV
Name Salix Coronary Plaque Viz RV/LV
Company Artrya Limited Viz.ai
Description FDA-cleared, AI-driven, web-based software that provides near real-time, point-of-care assessment of coronary artery plaque and stenosis from CCTA scans, aiding in the rapid and accurate diagnosis of coronary artery disease. FDA-cleared AI algorithm that automates right and left ventricular diameter measurements from CTPA scans, providing a crucial RV/LV ratio for rapid pulmonary embolism risk stratification and enhanced care coordination within the Viz PE Solution.
Primary Categories Cardiology AI Cardiology AI, Clinical Decision Support & Reference, Radiology & Imaging AI
Key Features AI-enabled CCTA analysis, Near real-time, point-of-care assessment, Detection and quantification of coronary plaque (atherosclerosis), Identification of high-risk plaque features (e.g., low-attenuation plaque, spotty calcification, positive remodeling, napkin-ring sign), Stenosis assessment, Quantification of calcifications (calcium scoring), Integrated workflow management, Automated report generation (editable). Automated Right Ventricle (RV) to Left Ventricle (LV) ratio measurement, Analysis of volumetric CTPA acquisitions, AI algorithm for identification and measurement of heart ventricles, Provides annotated images showing ventricular measurements, Seamless component of the Viz PE Solution for suspected pulmonary embolism detection, AI-powered alerts and notifications to care teams, High-fidelity mobile DICOM image viewer, HIPAA-compliant communication platform for care coordination.

Videos

Demos, reviews, and walkthroughs featuring Salix Coronary Plaque and Viz RV/LV.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Salix Coronary Plaque is designed for the near real-time, point-of-care assessment of coronary artery plaque and stenosis from CCTA scans, aiding in the rapid and accurate diagnosis of coronary artery disease. Viz RV/LV automates right and left ventricular diameter measurements from CTPA scans to provide a crucial RV/LV ratio for rapid pulmonary embolism risk stratification.
Salix Coronary Plaque analyzes CCTA (Coronary CT Angiography) scans to assess coronary artery disease. Viz RV/LV analyzes volumetric CTPA (CT Pulmonary Angiography) acquisitions to measure heart ventricles for pulmonary embolism risk stratification.
Salix Coronary Plaque provides detection and quantification of coronary plaque, identification of high-risk plaque features, stenosis assessment, and quantification of calcifications. Viz RV/LV provides automated right and left ventricular diameter measurements, specifically the RV/LV ratio, and annotated images showing these measurements.
Salix Coronary Plaque offers integrated workflow management and automated, editable report generation. Viz RV/LV is a seamless component of the Viz PE Solution, providing AI-powered alerts and notifications to care teams and a HIPAA-compliant communication platform for care coordination.
Salix Coronary Plaque operates on a per-scan assessment model with a stated US CPT reimbursement rate of US$950 per assessment. Pricing details for Viz RV/LV are not publicly available.
Salix Coronary Plaque is primarily intended for Cardiology and Radiology specialties. Viz RV/LV is relevant for Emergency Medicine, Pulmonology, and Radiology specialties.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.